CORAL SPRINGS, Florida, April 29, 2015 /PRNewswire/ --
The multi-billion dollar market of nutritional supplements combined with increased global distribution channels continues to fuel growth potential in the healthcare, pharmaceutical & nutritional supplement Industries as some industry analysts expect the nutrition supplement market to reach $175Billion globally by 2020. Consumer awareness regarding the benefits of dietary supplements and new product availability are the major drivers for the market world-wide. Nutritional Health Product Companies in focus today are: Axxess Pharma Inc. (OTC: AXXE), Celsius Holdings, Inc., (OTC: CELH), GNC Holdings Inc. (NYSE: GNC) and Pfizer Inc. (NYSE: PFE).
Axxess Pharma Inc. (OTC: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that they have been approved by Canada's leading health product franchise, "Nutrition House" to sell its full line of Tapout products. The Tapout products will be available in over 60 high profile shopping centers across Canada by early summer. Nutrition House determined Axxess Pharma's all-natural Tapout product line, including their high potency Omega 3 Fish Oil supplements and all-natural, gluten free, protein shakes are an excellent synergy for their health conscious customers. Nutrition House anticipates strong demand for the Tapout line, as more customers become aware of the all-natural Tapout products on their shelves.
Read the full AXXE press release at http://www.financialnewsmedia.com/profiles/axxe.html
Nutrition House is known through-out Canada for providing the highest grade of products to their customers. These products include national brands of vitamins, supplements, body care, sports nutrition products, as well as exclusive nutrition house extra products, and co-branded extra-value products, packaged exclusively for nutrition house by national brand suppliers. Nutrition House products can be purchased in their stores or online at http://www.nutritionhouse.com/ This agreement is part of Axxess Pharmas aggressive push to continue the expansion of their all-natural Tapout line into shopping centers, pharmacies and major brick and mortar retail supermarket chains across Canada and the United States. Axxess Pharma has also continued to expand globally through industry leading natural health distributors.
Earlier this year Axxess Pharma Inc. announced they presented their full TapouT line of products at the nation's largest health and fitness expo, known as the "The Arnold Fitness Expo" which was founded by Arnold Schwarzenegger, former Mr. Universe and 7 time Mr. Olympia. Over 175,000 fitness enthusiasts attended the three day non-stop event and competitions, including the Arnold Strongman Classic, and Arnold Arm Wrestling Classic. During the 3 day event, Axxess Pharma occupied two booths, with one strategically located next to the globally recognized World Wrestling Entertainment (NYSE: WWE) booth. Axxess Pharma also met with buyers from specialty chain stores, where they presented the full line of TapouT products including Ready-To-Drink (RTDs) protein shakes and supplements.
In other performance, nutrition & sports accessories news and happenings: Celsius Holdings, Inc., (OTC: CELH) is the creator and marketer of Celsius®, the world's first Negative Calorie and Fat Burning beverage with significant benefits to consumers focused on accelerating weight loss, fitness and a healthier lifestyle. Celsius provides clean energy and is backed by clinical science, and announced last week an investment of $15.95 million led by Hong Kong based Horizons Ventures, a private investment arm of Mr. Li Ka-Shing, Mr. Russell Simmons and Ms. Kimora Lee Simmons. The investment led by Horizons Ventures, Russell Simmons and Kimora Lee Simmons confirms the vision of long time Celsius investor Carl DeSantis, who founded Rexall Sundown and grew it into the world's leading Vitamin Company. Mr. DeSantis sold Rexall Sundown for $1.8 billion in 2000 and made a strategic investment in Celsius in 2007.
GNC (NYSE: GNC), the country's largest specialty retailer of dietary supplements, has agreed to institute sweeping new testing procedures on its herbal products that far exceed quality controls mandated under federal law. The action that was announced comes after the New York State attorney general's office accused GNC and three other major retailers of selling herbal supplements that were fraudulent or contaminated with unlisted ingredients that could pose health risks to consumers. Experts said the announcement marked an initial but significant step forward for the $33 billion-a-year supplement industry, which is loosely regulated and plagued by accusations of adulteration and mislabeling. Read the full article at http://well.blogs.nytimes.com/2015/03/30/gnc-to-strengthen-supplement-quality-controls/?_r=0
Under Armour, Inc. (NYSE: UA) last week announced financial results for the first quarter ended March 31, 2015. Net revenues increased 25% in the first quarter of 2015 to $805 million compared with net revenues of $642 million in the prior year's period. On a currency neutral basis, net revenues increased 27% compared with the prior year's period. Net income decreased 13% in the first quarter of 2015 to $12 million compared with $14 million in the prior year's period, inclusive of costs related to the previously announced acquisitions of Endomondo and MyFitnessPal during the first quarter. Diluted earnings per share for the first quarter of 2015 were $0.05 compared with $0.06 per share in the prior year's period. Read the full report at http://finance.yahoo.com/news/under-armour-reports-first-quarter-110000601.html
In other healthcare products news and happenings: China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), a leading China-based retail and wholesale distributor that offers pharmaceutical and health care products through its online and retail pharmacies, announced this week its subsidiary, Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. ("Jiuzhou Pharmacy") has signed a new sales incentive agreement with Wyeth Pharmaceutical Company, Ltd. ("Wyeth"), a wholly owned subsidiary in China of Pfizer Inc. (NYSE: PFE) (the "Agreement"). The purpose of the Agreement is to double the sales of Wyeth's Consumer Healthcare products in 2015. Jiuzhou Pharmacy has been partnering with Wyeth since 2003, and today it has become the largest retailer in Zhejiang Province for a variety of Wyeth's Consumer Healthcare products, such as Centrum (multivitamin & mineral supplements) and Caltrate (calcium supplement).
The Cleveland Cavaliers have announced a partnership with MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company. Under the agreement, MusclePharm Combat Crunch, a performance-tested, high-protein bar, will be the premier partner of the Cleveland Cavaliers and the exclusive presenting partner of the "Fourth Quarter Combat Crunch Time" in-game feature during select playoff home games at Quicken Loans Arena. The partnership also includes in-arena signage and branding, digital promotions and sweepstakes, and product sampling at designated Cavaliers games.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by Axxess Pharma Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
SOURCE FN Media Group LLC